Jefferies Group's HRMY Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 93,400 shares of Harmony Biosciences Holdings, Inc. (HRMY) worth $3.4 M, representing 0.02% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in HRMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 166,100 shares. Largest reduction occurred in Q4 2025, reducing 173,704 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Harmony Biosciences Holdings (HRMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Harmony Biosciences Holdings (HRMY) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +93,400 | New Buy | 93,400 | $36.41 |
| Q1 2026 | -29,251 | Sold Out | 0 | $0.00 |
| Q4 2025 | -173,704 | Reduce 85.59% | 29,251 | $37.42 |
| Q3 2025 | +32,385 | Add 18.99% | 202,955 | $27.56 |
| Q2 2025 | +26,326 | Add 18.25% | 170,570 | $31.60 |
| Q1 2025 | -161,356 | Reduce 52.80% | 144,244 | $33.19 |
| Q4 2024 | +89,000 | Add 41.09% | 305,600 | $34.41 |
| Q3 2024 | +166,100 | Add 328.91% | 216,600 | $40.00 |
| Q2 2024 | +25,000 | Add 98.04% | 50,500 | $30.17 |
| Q1 2024 | +4,800 | Add 23.19% | 25,500 | $33.58 |
| Q4 2023 | +20,700 | New Buy | 20,700 | $32.30 |
| Q3 2023 | -10,000 | Sold Out | 0 | $0.00 |
| Q2 2023 | +10,000 | New Buy | 10,000 | $35.19 |
Jefferies Group's Harmony Biosciences Holdings Investment FAQs
Jefferies Group first purchased Harmony Biosciences Holdings, Inc. (HRMY) in Q2 2023, acquiring 10,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Harmony Biosciences Holdings, Inc. (HRMY) for 13 quarters since Q2 2023.
Jefferies Group's largest addition to Harmony Biosciences Holdings, Inc. (HRMY) was in Q3 2024, adding 216,600 shares worth $8.66 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 93,400 shares of Harmony Biosciences Holdings, Inc. (HRMY), valued at approximately $3.4 M.
As of the Q2 2026 filing, Harmony Biosciences Holdings, Inc. (HRMY) represents approximately 0.02% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Harmony Biosciences Holdings, Inc. (HRMY) was 305,600 shares, as reported at the end of Q4 2024.